Predictions
13 of 1,607 predictions match — page 1 of 1. Click any row to view its detail.
Filters
Domain
AllAIAI/AgentsAI/AGIAI/ArchitectureAI/ChinaAI/CognitionAI/ComputeAI/CorporateAI/FinanceAI/HardwareAI/InfrastructureAI/ManufacturingAI/MarketsAI/MathematicsAI/PhysicsAI/SoftwareAI/StartupsAI/StrategyAuto/TransportBiotech/LongevityCapital MarketsConsumerCryptoDefenseEconomyEconomy/OrgEducationEnergyEnergy/ComputeFinance/CryptoGeopoliticsInvestingLabor/JobsMacro/EconomyManufacturingMarkets/StocksMedia/AdsOtherPolicy/SemisQuantumQuantum/AIReal EstateRoboticsSemisSemis/ASICsSemis/GeopoliticsSemis/HardwareSemis/MarketsSemis/MemorySemis/PackagingSemis/Productsshort_horizon_breakoutSpaceSpace/ComputeTechnology
Predictor
| ID | Domain | Topic | Title | Predictor | Conv | SQ | Prior | Status | Window |
|---|---|---|---|---|---|---|---|---|---|
| 235_027 | Biotech/Longevity | synbio | Longevity VC market expected to grow from $8.5B in 2024 to $12-18B in 2026. | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-01-01 – 2026-09-30 |
| 235_029 | Biotech/Longevity | synbio | Big pharma companies will transition into longevity business in next 3 years. | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-01-01 – 2029-11-30 |
| 247_032 | Biotech/Longevity | AI-timing | Full cell simulation achievable within 5 years | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-01-01 – 2031-09-30 |
| 247_041 | Biotech/Longevity | AI-timing | AI-powered drugs have 85% phase 1 success vs 52% traditional | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-01-01 – 2026-06-30 |
| 235_038 | Biotech/Longevity | AI-timing | David Sinclair begins partial epigenetic reprogramming trials with Life Biosc… | Peter Diamandis | 5/5 | B | 92.0% | hit | 2026-03-01 – 2026-03-31 |
| 234_028 | Biotech/Longevity | AI-timing | Lab grown meat will replace conventional meat as the healthier environmental … | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-04-30 – 2031-12-31 |
| 245_005 | Biotech/Longevity | synbio | Countries will become customers to preserve endangered species via Colossal | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-04-30 – 2030-12-31 |
| 245_009 | Biotech/Longevity | AI-timing | Breaking plastic-degradation technology could become a supplement that breaks… | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-04-30 – 2027-09-30 |
| 245_011 | Biotech/Longevity | synbio | Colossal is spinning out a dozen companies each with massive potential | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-04-30 – 2028-12-31 |
| 245_042 | Biotech/Longevity | $100T | Synthetic biology will be as diverse a market as AI (multi-trillion) | Peter Diamandis | 4/5 | A | 65.0% | pending | 2026-04-30 – 2031-12-31 |
| AUT_027 | Biotech/Longevity | Longevity-Escape-Velocity-2027 | Integration of AI with advanced bio-sensing, quantum computing, and genomics … | Peter Diamandis | 5/5 | B | 22.0% | pending | 2027-01-01 – 2035-09-30 |
| 235_028 | Biotech/Longevity | $100T | Longevity market will grow from $5 trillion to $8 trillion in next four years. | Peter Diamandis | 4/5 | B | 65.0% | pending | 2030-01-01 – 2030-06-30 |
| 233_015 | Biotech/Longevity | synbio | Infinite longevity is coming for this generation of kids. | Peter Diamandis | 4/5 | B | 65.0% | pending | 2070-06-01 – 2070-06-30 |